The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 25.71% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -6.38%. Over the past 30 days, the price of INBS has leaped by -21.08%. And in the last five days, it has fallen by -16.98%.
Intelligent Bio Solutions Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $4.64 on 03/28/24 and a low of $1.00 for the same time frame on 08/16/24.
52-week price history of INBS Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Intelligent Bio Solutions Inc’s current trading price is -62.07% away from its 52-week high, while its distance from the 52-week low is 76.00%. The stock’s price range during this period has varied between$1.00 and $4.64. The Intelligent Bio Solutions Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.53 million for the day, a figure considerably higher than their average daily volume of 0.2 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Intelligent Bio Solutions Inc (INBS) has experienced a quarterly rise of 38.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.94M and boasts a workforce of 50 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.73, with a change in price of +0.17. Similarly, Intelligent Bio Solutions Inc recorded 182,289 in trading volume during the last 100 days, posting a change of +10.69%.
INBS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for INBS stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.00.
INBS Stock Stochastic Average
Intelligent Bio Solutions Inc’s raw stochastic average for the past 50 days is presently 33.10%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 7.50%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 27.92% and 34.17%, respectively.
